期刊论文详细信息
Malaria Journal | |
Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria | |
Commentary | |
Frank O. Richards1  | |
[1] River Blindness, Lymphatic Filariasis and Schistosomiasis Programs, The Carter Center, 453 Freedom Parkway, 30307, Atlanta, GA, USA; | |
关键词: Malaria; Ivermectin; Albendazole; Lymphatic Filariasis; Mass Drug Administration; | |
DOI : 10.1186/s12936-017-1830-z | |
received in 2017-04-17, accepted in 2017-04-18, 发布年份 2017 | |
来源: Springer | |
【 摘 要 】
Ivermectin mass drug administration (MDA) in humans to reduce malaria vectors is yet another use for this remarkable medicine whose discoverers shared the 2015 Nobel Prize in Medicine with the discoverer of artemisinin. The malaria community should join those who have long used ivermectin MDA in an integrated battle to break transmission of three vector-borne parasitic diseases.
【 授权许可】
CC BY
© The Author(s) 2017
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311103172065ZK.pdf | 893KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]